Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 22.7B | 20.6B | 20.6B | 20.3B |
Cost of revenue | 15.5B | 18.6B | 18.6B | 18.3B |
Gross profit | 7.2B | 2.0B | 2.1B | 1.9B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | -458M | 1.4B | 1.3B | 1.2B |
Operating income | 1.5B | 1.3B | 1.4B | 1.3B |
Non operating interest income | ||||
Income | -65M | 79M | 108M | 99M |
Expense | 148M | 289M | 314M | 282M |
Other income expense | — | — | — | — |
Pretax income | 1.6B | 1.2B | 1.2B | 1.1B |
Tax provision | 459M | 347M | 345M | 344M |
Net income | 1.2B | 811M | 805M | 802M |
Basic EPS | — | 0.6 | 0.6 | 0.6 |
Diluted EPS | — | 0.6 | 0.6 | 0.6 |
Basic average shares | — | 1.2B | 1.2B | 1.2B |
Diluted average shares | — | 1.2B | 1.2B | 1.2B |
EBITDA | 3.0B | 2.6B | 2.6B | 2.6B |
Net income from continuing op. | 1.2B | 811M | 805M | 802M |
Minority interests | -57M | -60M | -61M | -59M |
Preferred stock dividends | 0 | 0 | 0 | 0 |